Coadministration of Ezetimibe and Simvastatin in Patients With Primary Hypercholesterolemia (P05457)
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
Evaluate the safety of the long-term (1 year) coadministration of ezetimibe and simvastatin
in patients with hypercholesterolemia who have not reached low density lipoprotein
(LDL)-cholesterol target with 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase
inhibitors.